MedPath

Hydroxyzine

Generic Name
Hydroxyzine
Brand Names
Atarax, Vistaril
Drug Type
Small Molecule
Chemical Formula
C21H27ClN2O2
CAS Number
68-88-2
Unique Ingredient Identifier
30S50YM8OG

Overview

Hydroxyzine is a first-generation histamine H-receptor antagonist of the dephenylmethane and piperazine classes that exhibits sedative, anxiolytic, and antiemetic properties. It was first developed in 1955, and has since remained a relatively common treatment for allergic conditions such as pruritus, urticaria, dermatoses, and histamine-mediated pruritus. The active metabolite of hydroxyzine, cetirizine, is also available as an active ingredient in allergic medications, and is responsible for much of its hydroxyzine's antihistaminic effect. Hydroxyzine is also used for generalized anxiety disorder, tension caused by psychoneurosis, and other conditions with manifestations of anxiety.

Background

Hydroxyzine is a first-generation histamine H-receptor antagonist of the dephenylmethane and piperazine classes that exhibits sedative, anxiolytic, and antiemetic properties. It was first developed in 1955, and has since remained a relatively common treatment for allergic conditions such as pruritus, urticaria, dermatoses, and histamine-mediated pruritus. The active metabolite of hydroxyzine, cetirizine, is also available as an active ingredient in allergic medications, and is responsible for much of its hydroxyzine's antihistaminic effect. Hydroxyzine is also used for generalized anxiety disorder, tension caused by psychoneurosis, and other conditions with manifestations of anxiety.

Indication

Hydroxyzine is indicated for the symptomatic relief of anxiety and tension associated with psychoneuroses, and as an adjunct in organic disease states in which anxiety is manifested. It is also indicated in the treatment of histamine-mediated pruritus and pruritus due to allergic conditions such as chronic urticaria. Canadian labeling states that hydroxyzine is also indicated in adults and children as a premedication prior to medical procedures, such as dental surgery. It is also used in the control of nausea and vomiting, excluding nausea and vomiting of pregnancy.

Associated Conditions

  • Anxiety
  • Nausea and vomiting
  • Pruritus

FDA Approved Products

Hydroxyzine Hydrochloride
Manufacturer:RedPharm Drug Inc.
Route:ORAL
Strength:25 mg in 1 1
Approved: 2011/07/14
NDC:67296-0055
HYDROXYZINE HCL
Manufacturer:DIRECT RX
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/04/13
NDC:61919-856
HYDROXYZINE HCL
Manufacturer:DIRECT RX
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/04/13
NDC:61919-217
Hydroxyzine Hydrochloride
Manufacturer:Chartwell RX, LLC
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/06/29
NDC:62135-545
HydrOXYzine Hydrochloride
Manufacturer:NuCare Pharmaceuticals,Inc.
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/07/06
NDC:68071-3450

Singapore Approved Products

HYDROXYZINE MEVON FILM-COATED TABLETS 10 MG
Manufacturer:Centaur Pharmaceuticals Pvt Ltd, Medreich Limited
Form:TABLET, FILM COATED
Strength:10.000 mg
Online:Yes
Approved: 2021/09/21
Approval:SIN16329P
HIZIN TABLET 10 mg
Manufacturer:OLIC (THAILAND) LTD
Form:TABLET
Strength:10 mg
Online:Yes
Approved: 1989/06/16
Approval:SIN03423P
HYDROXYZINE MEVON FILM-COATED TABLETS 25 MG
Manufacturer:Centaur Pharmaceuticals Pvt Ltd, Medreich Limited
Form:TABLET, FILM COATED
Strength:25.000 mg
Online:Yes
Approved: 2021/09/21
Approval:SIN16328P
HIZIN 25 TABLET 25 mg
Manufacturer:OLIC (THAILAND) LTD
Form:TABLET
Strength:25 mg
Online:Yes
Approved: 1989/06/16
Approval:SIN03422P
AA PHARMA HYDROXYZINE CAPSULE 10 mg
Manufacturer:CATALENT ONTARIO LIMITED
Form:CAPSULE
Strength:10 mg
Online:Yes
Approved: 1990/03/07
Approval:SIN04096P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath